The authors would like to declare the following patents/patent applications associated with this research: JP 4627841, 5639759, 4609845, 4942001, 5283173, 4822272, 5633952, and 5715046
Hyperglucagonemia is associated with type 1 and type 2 diabetes, leading to increased hepatic glucose production and hyperglycemia 39,40,41
A person using a GLP-1 may be trying to lower blood sugar, reduce joint pain, quiet relentless hunger or reclaim energy
Consistent with findings in adult mouse models of obesity 30 , chronic semaglutide treatment lowered fasting glycemia and insulinemia in juvenile mice (Fig
Patients should be counseled on the importance of reporting any new or worsening symptoms promptly, and healthcare providers should remain vigilant in monitoring for signs of gallbladder complications